Treating breast cancer with a combination of chemotherapy and the cancer drug Avastin "is not clinically meaningful," according to an FDA document published online on Friday, Dow Jones/Wall Street Journal reports. FDA said the level of improvement in women treated with chemotherapy and Avastin was not significantly better than in women who received chemotherapy alone...
More...